# FDA 483 - Eli Lilly & Company - June 16, 2023

Source: https://www.globalkeysolutions.net/records/483/eli-lilly-company/930f2d4f-2241-4d16-9fef-ce8687021194

> FDA 483 for Eli Lilly & Company on June 16, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Eli Lilly & Company
- Inspection Date: 2023-06-16
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/eli-lilly-company/15ef318d-09d2-403d-a119-ae8f9a4a6fc9)
- [483 - 2023-06-16](https://www.globalkeysolutions.net/records/483/eli-lilly-company/a0b48bb1-5ab9-46d0-aa9d-29cc5079a354)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/eli-lilly-company/fb465d0f-eee0-4efe-b1ef-fd636964c59d)
- [EIR - 2020-01-17](https://www.globalkeysolutions.net/records/eir/eli-lilly-company/00535940-b628-4bcd-aa01-17eb95be770e)
- [483 - 2021-03-16](https://www.globalkeysolutions.net/records/483/eli-lilly-company/9fdf10fc-bc85-478c-affd-9279176c5cb7)

## Related Officers

- [Melina L. Rodriguez-Upton](https://www.globalkeysolutions.net/people/melina-l-rodriguez-upton/0b540980-5708-4251-8ea6-6254375506f1)
- [Debara R. Reese](https://www.globalkeysolutions.net/people/debara-r-reese/277a8fbb-ba4d-4402-be08-16d7977685db)
- [Senior Regulatory Specialist](https://www.globalkeysolutions.net/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942)

Company: https://www.globalkeysolutions.net/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd